Email a Friend
Printer Friendly
Slashdot It!
Submit to Reddit
Add to Facebook

New approach which can help to predict neurodegenerative diseases

July 27, 2010

New investigations, initiated by research workers at CIC bioGUNE and led by Dr. Aitor Hierro, have opened possibilities for making progress in the knowledge and prediction of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), according to the prestigious journal of The Proceedings of the National Academy of Sciences of the United States of America.

This study opens the possibility of research in humans to detect this pathology before the symptoms arise.

The research was undertaken in collaboration with groups from the National Institute of Health (NIH) and the Neuromuscular Center at the Cleveland Clinic, both in the USA, as well as from the National Centre for Scientific Research (CNRS) in France. They have described, for the first time ever, the structure of a protein known as Vps54, one of the four making up the GARP complex of proteins.

Using the wobbler mouse as a model, the protein Vps54 has a mutation which gives rise to a progressive degeneration of the motor neurones and to infertility. Given this characteristic phenotype, the wobbler mouse has been used since its discovery in 1956 by Dr. Falconer as a model for the study of the spontaneous degeneration of motor neurones, including Amyotrophic Lateral Sclerosis.

In 2005 Dr. Jockusch's team managed to identify the mutation responsible for the wobbler phenotype. From this moment the team led by Dr. Hierro focused on understanding how this mutation affected the protein and its own activity.

In this way it was discovered that the disease is not only the consequence of a mutation of a concrete protein - a thesis held to date on the basis of previous studies -, but that there exists a domino effect in which reduced levels of the mutated protein have a destabilising effect on the rest of the components of the GARP complex of which they form part. "The illness develops not only because of the mutation but it may also be due to other mutations or defects that generate reduced levels of the GARP complex or instability therein", explained Dr Hierro.

There exists a study undertaken at the University of Michigan by Dr. Brown with 96 patients suffering from sporadic ALS and in which this mutation present in the wobbler mouse was not found and so it can be concluded that this mutation has no great presence amongst humans. "Nevertheless, the great similarity between the GARP complex proteins of the mouse and amongst humans means that such that a motorneurodegenerative effect in humans due to reduced levels of the GARP mooring complex cannot be discarded This opens the possibility for studying these levels in humans where, moreover, it will be possible to predict the illness well before the appearance of symptoms", explained Dr Hierro. "It is highly likely that many patients with some motorneurodegenerative disease do not have the same mutation as the wobbler mouse but there does exist the possibility that, due to some other reason, some patients may have reduced levels of the GARP complex, a situation which gives rise to the illness", stated Dr Hierro.

To carry out this research, various techniques such as x-ray crystallography, together with bioinformatic analysis, have been used, enabling resolving for the first time the structure of the mentioned protein in the region where the mutation is produced. Subsequently a combination of in vitro experiments were undertaken using biophysical techniques, as well as in vivo ones using various mouse cell lines and tissues with the wobbler phenotype, and it was confirmed that the mutation produces a destabilising effect on the Vps54 protein, an effect that is subsequently transmitted to the rest of the components of the GARP protein complex.

Regulation of cell 'traffic'

The metabolic balance of the cell largely depends on the correct transport of components amongst the various cell organelles, something similar to the great transport networks between cities or ports. The cargo 'vehicles' used for this transport are mostly the vesicles, small lipid spheres that arise from the cell organelle and are transported to another cell organelle. This transport is exquisitely regulated and the defects that may arise could be the cause of the illness.

Many proteins act together for sustaining life, forming what are known as protein complexes (a series of proteins that develop a specific function). The GARP complex is the transport network that recycles receptors of acid hydrolases from the lysosomes (the stomach of the cell) to the Golgi apparatus. Acid hydrolases are enzymes which, in the acidic medium of the lysosomes, are activated and digest other proteins. To avoid the receptors themselves being digested by the acid hydrolases, once the interior of the lysosomes is acidified, these recycle to the Golgi by means of transport vesicles. In this way, the receptors are recycled and reused to transport new acid hydrolases to the lysosomes. In concrete, the GARP complex is formed by four proteins and is responsible for physically tying up the vesicles that are transported to the destination organelle, in this case the Golgi apparatus, something similar to a vessel being moored at a port. Subsequently the vesicles fuse to discharge their transported content.

The study concluded that the wobbler phenotype is the consequence of a drastic reduction in the levels of the GARP complex, one that is required to tie up the transport vesicles to the Golgi apparatus. This drop in the levels of the GARP complex thus breaks with the normal functioning of the recycling route of the acid hydrolase receptors to the Golgi apparatus.

Elhuyar Fundazioa

Related Neurodegenerative Diseases Current Events and Neurodegenerative Diseases News Articles

Neurodegenerative Diseases Current Events and Neurodegenerative Diseases News RSS

UCI-Scripps study links cellular motors to memory
Functioning much like gears in a machine, cellular motor proteins are critical to dynamic functions throughout the body, including muscle contraction, cell migration and cellular growth processes.

Lipid peroxides -- more sophisticated than their reputation
In a joint study conducted by Helmholtz Zentrum München, the German Center for Neurodegenerative Diseases (DZNE) and a research group at Karolinska Institutet in Stockholm, Sweden, researchers have now discovered that lipid peroxides play a specific physiological role in the cell.

New sporadic prion protein disease identified by Case Western Reserve
A new sporadic prion protein disease has been discovered. Variably protease-sensitive prionopathy (VPSPr), as it has been named, is the second type of complete sporadic disease to be identified since Creutzfeldt-Jakob disease (CJD) was reported in the 1920s.

Neurodegeneration 'clumping proteins' common in aging process
Many proteins that form insoluble clumps in the brains of people with Alzheimer's and other neurodegenerative diseases are also found in healthy individuals and clump together as a normal part of aging.

Proteins linked with Alzheimer's, other neurodegenerative diseases found to clump in normal aging
In neurodegenerative diseases, clumps of insoluble proteins appear in patients' brains. These aggregates contain proteins that are unique to each disease, such as amyloid beta in Alzheimer's disease, but they are intertwined with small amounts of many other insoluble proteins that are normally present in a soluble form in healthy young individuals.

Calcium Connections: Penn Researchers Discover Basic Pathway for Maintaining Cell's Fuel Stores
University of Pennsylvania School of Medicine researchers have described a previously unknown biological mechanism in cells that prevents them from cannibalizing themselves for fuel.

Research project analyses cerebral bioelectricity in order to detect epilepsy
A group of researchers from Universidad Carlos III de Madrid (UC3M) has presented a new algorithm that uses a new method to analyse the information obtained from electroencephalograms to detect neurodegenerative diseases, such as epilepsy, using the bioelectric signals of the brain.

New role for the JNK protein
Put simply, a tumor is the result of out-of-control cell growth. To assure that the cell cycle - the cell's process of duplicating itself to make more cells - goes smoothly, a large network of proteins tells other proteins what to do and when to do it.

Opening the gate to the cell's recycling center
In cells, as in cities, disposing of garbage and recycling anything that can be reused is an essential service. In both city and cell, health problems can arise when the process breaks down.

Surgery linked to Creutzfeldt-Jakob disease
"Based on the monitoring records of spongiform encephalopathy in two Nordic countries, we studied the possibility of transmission of the sporadic form of CJD through general surgery", explains Jesús de Pedro, main author of the study and head of prion monitoring in patients at the National Epidemiology Centre of the Carlos III Health Institute.

More Neurodegenerative Diseases Current Events and Neurodegenerative Diseases News Articles

	Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics by M. Flint Beal (Author), Anthony E. Lang (Author), Albert C. Ludolph (Author) Neurodegenerative diseases are major contributors to disability and disease, with Alzheimer's and Parkinson's diseases the most prevalent. This major reference reviews the rapidly advancing knowledge of pathogenesis and treatment of neurodegenerative diseases in the context of a comprehensive survey of each disease and its clinical features. The editors and contributors are among the leading experts in the field internationally. Covering basic science, diagnostic tools and therapeutic approaches, the book focuses on all aspects of neurodegenerative disease, including the normal aging process. The dementias, prion diseases, Parkinson's disease and atypical parkinsonisms, neurodegenerative ataxias, motor neuron diseases, degenerative diseases with chorea, iron and copper disorders, and...
	Protein folding and misfolding: neurodegenerative diseases (Focus on Structural Biology) by Springer The worldwide increasing age of populations brought the neurodegenerative diseases into the focus of interest. A number of the diverse human neurodegenerative diseases are now recognized as conformational diseases frequently caused by aggregations of unfolded or misfolded proteins. Knowledge on the intrinsically unstructured proteins, a new family of gene products as well as on the misfolded proteins produced by genetic mutation or environmental effects has been extensively accumulated in the past years. These proteins frequently cause proteolytic stress and/ or enter into aberrant, non-physiological protein-protein interactions leading to sequestration of protein aggregates which are assemblies of many not-yet-identified components in addition to the deposition of well-characterized...
	So Much So Fast Starring: Stephen Heywood, Jamie Heywood Directed By: Steven Ascher;Jeanne Jordan What would you do if you were 29 and found you may only have a few years to live? So Much So Fast is about the remarkable events set in motion when Stephen Heywood discovers he has ALS (Lou Gehrig's disease) and his brother Jamie becomes obsessed with finding a cure.
	Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience) by Marie-Francoise Chesselet (Editor) Univ. of California, Los Angeles. First volume in this series. Synthesizes novel ideas and concepts emerging to create a fresh understanding of neurodegenerative disorders, details mechanistic similarities in Alzheimer's, Parkinson's, and related diseases. DNLM: Neurodegenerative Diseases--genetics.
	CoQSol CF 100 mg 120 Softgels by Doctor's Best Coqsol-cf is a patent pending formulation of crystal-free coenzyme q10 solubilized in d-limonene oil. the formula also includes mixed tocopherols.coq10 is a nutrient that supports heart function and promotes energy production in cells. coq10 is a versatile antioxidant, which stabilizes cell membranes, protecting them from free radical damage. coq10 can also powerfully support immune function.coqsol-cf provides the well-known benefits of coenzyme q10 in a formula designed for enhanced bioavailability. coq10 is itself a highly unstable molecule that is prone to crystallization upon exposure to heat, light and air. many coq10 products are, therefore, highly crystallized. this crystallization process may decrease the absorption and bioavailability of the coq10. coqsol-cf solves this problem...
	MANAGEMENT OF PARKINSON'S DISEASE Strategies, pitfalls, and future directions A concise overview of clinical diagnosis, current therapeutic options, and ... strategies for addressing neurodegeneration. by JTE Multimedia Abstract: As the population ages, the incidence of Parkinson's disease is likely to increase. Unfortunately, the diagnosis can be complex, and current treatment options offer symptomatic relief in many patients but no cure for the underlying neurodegeneration. In this article, Dr Hermanowicz offers a concise overview of possible etiologic factors, clinical features, treatment principles and practice, and new therapeutic approaches that may improve management of Parkinson's disease in the future.
	Glia And Inflammation in Neurodegenerative Disease (Nova Biomedical) by M. A. Yenari (Editor), R. G. Giffard (Editor) The brain has long been considered an immune privileged organ, meaning that inflammatory cells are excluded due to a relatively impenetrable blood brain barrier (BBB). However, this is not to say that the central nervous system is incapable of eliciting immune responses, as resident inflammatory cells exist within the brain parenchyma. Microglia have long been thought to be the brain's resident immune cell with myeloid lineage similar to monocytes and macrophages. In this volume, the authors review the current state of knowledge with regard to immune responses and cell-cell interactions as they pertain to a variety of neurodegenerative diseases. The changing role of inflammation with development is considered. They also present a summary of the various therapeutic strategies employed both...
	Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience) by Humana Press Univ. of California, Los Angeles. First volume in this series. Synthesizes novel ideas and concepts emerging to create a fresh understanding of neurodegenerative disorders, details mechanistic similarities in Alzheimer's, Parkinson's, and related diseases. DNLM: Neurodegenerative Diseases--genetics.
	So Much So Fast DVD Starring: Robert Bonazoli, Ken Thompson Directed By: Steven Ascher, Jeanne Jordan Also With: Stephen Heywood (Primary Contributor), Jamie Heywood (Primary Contributor), Wendy Stacy Heywood (Primary Contributor), Ben Heywood (Primary Contributor), Melinda Marsh Heywood (Primary Contributor), Peggy Heywood (Primary Contributor), John Heywood (Primary Contributor), Steven Ascher (Producer), Jeanne Jordan (Producer) From Oscar-nominated directors Steven Ascher and Jeanne Jordan (Troublesome Creek), comes a new documentary that's a black-humored cliffhanger of romance, guerilla science and the meaning of time. What would you do if you were 29 and found you may only have a few years to live? So Much So Fast is about the remarkable events set in motion when Stephen Heywood discovers he has ALS (Lou Gehrig's disease) and his brother Jamie becomes obsessed with finding a cure. Nominated for Grand Jury Prize at the Sundance Film Festival, So Much So Fast was released theatrically to critical acclaim and was broadcast on networks around the world, including the premier PBS series Frontline. "Triumphant! A story that keeps expanding until it seems to fill the universe. Unforgettable." Four stars - Boston...
	Protective Strategies For Neurodegenerative Diseases (Annals of the New York Academy of Sciences 1035) by Debomoy K. Lahiri (Editor) The incidence of age-related neurodegenerative diseases can be expected to rise dramatically in the future owing to an aging population. Consequently, finding the means of retarding the progression of such diseases becomes increasingly important. This volume focuses on research findings involving both nutritional and pharmacological strategies for slowing normal brain aging and its pathological variants such as Alzheimer's and Parkinson's diseases. Scientists well recognized for their molecular and mechanistic work in this area have contributed chapters to this volume. New concepts concerning neurodegenerative disease and its mitigation are also included in this volume, which is designed to promote the development of fresh research perspectives and therapeutic possibilities directed...